+1 (202) 780-3397
Commentary - Hematology and Blood Disorders (2020) Volume 3, Issue 2
Gemcitabine-carbon nitride dots as nanocarrier to target specifically pediatric glioma tumors
The article discusses a study to target-specific gemcitabine delivery to pediatric glioblastoma tumors across the blood-brain barrier (BBB) using carbon nitride dots (CNDs) as a nanocarrier . CNDs can be identified as a third-generation novel nano dot material after semiconductor metal quantum dots and carbon dots. Similar to its predecessor carbon dots, CNDs have excellent stability, water dispersibility and non-toxic properties in comparison to the metal quantum dots.
Author(s): Roger M. Leblanc, Piumi Y. Liyanage